Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia.
作者信息
Estey E, Keating M J, Plunkett W, McCredie K B, Freireich E J